🔎 Trials Near Me

首页 › 急性双表型白血病 › 华盛顿州

华盛顿州 的 急性双表型白血病 临床试验

华盛顿州 有 15 项针对 急性双表型白血病 的研究正在招募参与者。

华盛顿州 的城市

官方研究文本（英文）

A Phase 1 Study of Orca-Q in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies

  • Fred Hutchinson Cancer Center, Seattle
招募中1 期
12 至 78 岁 · 所有性别 · 更新于 2026年9月29日 · NCT03802695

Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia

  • Seattle Children's Hospital, Seattle
  • Providence Sacred Heart Medical Center and Children's Hospital, Spokane
招募中2 期
365 Days · 所有性别 · 更新于 2026年9月25日 · NCT06317662

CLAG-M or FLAG-Ida Chemotherapy and Reduced-Intensity Conditioning Donor Stem Cell Transplant for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Chronic Myelomonocytic Leukemia

  • Fred Hutch/University of Washington Cancer Consortium, Seattle
招募中1 期
18 岁及以上 · 所有性别 · 更新于 2026年9月17日 · NCT04375631

Randomization for the Identification of Best Treatment Intensity for Less Fit Adults With Acute Myeloid Leukemia and Myeloid Neoplasms

  • Fred Hutch/University of Washington Cancer Consortium, Seattle
招募中
18 岁及以上 · 所有性别 · 更新于 2026年9月17日 · NCT07094750

Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy

  • Seattle Children's Hospital, Seattle
  • Providence Sacred Heart Medical Center and Children's Hospital, Spokane
  • Mary Bridge Children's Hospital and Health Center, Tacoma
招募中3 期
365 Days – 25 Years · 所有性别 · 更新于 2026年8月25日 · NCT03959085

The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study

  • Seattle Children's Hospital, Seattle
  • Providence Sacred Heart Medical Center and Children's Hospital, Spokane
  • Mary Bridge Children's Hospital and Health Center, Tacoma
  • 以及另外 1 项
招募中1/2 期
22 岁及以下 · 所有性别 · 更新于 2026年8月25日 · NCT04726241

Cord Blood Transplant, Cyclophosphamide, Fludarabine, and Total-Body Irradiation in Treating Patients With High-Risk Hematologic Diseases

  • Fred Hutch/University of Washington Cancer Consortium, Seattle
招募中2 期
6 Months – 65 Years · 所有性别 · 更新于 2026年7月22日 · NCT06013423

Combination Chemotherapy (FLAG-Ida) Followed Immediately by Reduced-Intensity Total Body Radiation Therapy and Donor Hematopoietic Cell Transplant for the Treatment of Adults Age 60 and Older With Newly Diagnosed Adverse-Risk Acute Myeloid Leukemia or Other High-Grade Myeloid Cancer

  • Fred Hutch/University of Washington Cancer Consortium, Seattle
招募中2 期
18 岁及以上 · 所有性别 · 更新于 2026年7月20日 · NCT07046078

211^At-BC8-B10 Before Donor Stem Cell Transplant in Treating Patients With High-Risk Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndrome, or Mixed-Phenotype Acute Leukemia

  • Fred Hutch/University of Washington Cancer Consortium, Seattle
招募中1/2 期
18 至 75 岁 · 所有性别 · 更新于 2026年6月22日 · NCT03128034

211At-BC8-B10 Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory High-Risk Acute Leukemia or Myelodysplastic Syndrome

  • Fred Hutch/University of Washington Cancer Consortium, Seattle
招募中1/2 期
18 至 75 岁 · 所有性别 · 更新于 2026年6月22日 · NCT03670966

Donor Stem Cell Transplant With Treosulfan, Fludarabine, and Total-Body Irradiation for the Treatment of Hematological Malignancies

  • Fred Hutch/University of Washington Cancer Consortium, Seattle
招募中2 期欢迎健康志愿者
6 Months · 所有性别 · 更新于 2026年5月29日 · NCT04195633

HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant

  • Fred Hutch/University of Washington Cancer Consortium, Seattle
招募中1 期
80 岁及以下 · 所有性别 · 更新于 2026年5月18日 · NCT03326921

Chemotherapy (Decitabine in Combination With FLAG-Ida) and Total-Body Irradiation Followed by Donor Stem Cell Transplant for the Treatment of Adults With Myeloid Malignancies at High Risk of Relapse

  • Fred Hutch/University of Washington Cancer Consortium, Seattle
招募中1/2 期欢迎健康志愿者
18 岁及以上 · 所有性别 · 更新于 2026年5月15日 · NCT06928662

Venetoclax and CLAG-M for the Treatment of Acute Myeloid Leukemia and High-Grade Myeloid Neoplasms

  • Fred Hutch/University of Washington Cancer Consortium, Seattle
招募中1/2 期
18 岁及以上 · 所有性别 · 更新于 2026年4月17日 · NCT04797767

Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies

  • Seattle Children's Hospital, Seattle
招募中1 期
1 至 21 岁 · 所有性别 · 更新于 2024年12月6日 · NCT05476770

数据来自 ClinicalTrials.gov，检索日期：2026年10月5日。每项研究自行设定入选标准，由研究团队决定谁能参与。